Lilly is a medicine company turning science into healing to make life better for people around the world.
04:32-04:39 [A black background with "Eli Lilly and Company thanks all participants and volunteers of clinical studies. Without these heroes, scientific breakthroughs in medicine would not be possible." in white text appears on the screen.] 04:40-04:44 [The screen fades to a red backgrou...
Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at...
Lilly(Eli) & CompanyNYSE: LLY$878.31 +$7.94 (+0.9%) Closing Price on February 7, 2025 LLY Stock Chart and Intraday Price LLY Stock Data Asset Type Stock Exchange NYSE Currency USD Country USA Sector LIFE SCIENCES Industry PHARMACEUTICAL PREPARATIONS Address LILLY CORPORATE CTR, DROP CODE 1094,...
Thank you, Paul, and good morning everyone. Thank you for joining us for Eli Lilly and Company's Q1 2024earnings callI'm Joe Fletcher, senior vice president of investor relations. And joining me on today's call are Dave Ricks, Lilly's chair and CEO; Anat Ashkenazi, chief financial office...
公司名称礼来公司英文名称Eli Lilly and Company注册地美国 成立日期1901总股数950177900所属行业制药 董事长David A. Ricks员工总数43000电子邮箱- 主要电话1-317-2762000主要传真-公司网站www.lilly.com 注册地详细地址美国印第安纳州 主要办公地址Lilly Corporate Center, Indianapolis, Indiana 46285 ...
Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at...
Eli Lilly & Company was one of the earliest signatories to the Sullivan Principles.1 Joining the Sullivan Principles was, indeed, consistent with the company’s overall posture of being a socially responsive company with a long history of community involvement. The company also had the good fortun...
INDIANAPOLIS,June 23, 2023/PRNewswire/ --Eli Lilly and Company(NYSE: LLY) announced today new phase 2 data for orforglipron, its first nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist being studied for chronic weight management in participants with obesity ...
Lilly's heritage and values are the foundation of the company's promise to unite caring and discovery for people around the world. Learn more about historic medications at Lilly.